Search clinical trials for: Pantoprazole

Total 451 results

First Affiliated Hospital of Zhejiang University
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Unknown

A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults（Part 2）

Safety Issues | Effect of Drugs

China
Cinclus Pharma AG
Parexel

Completed

A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole

Erosive Esophagitis

Poland, Bulgaria, Serbia, Georgia, United States, Czechia, Hungary, Ukraine
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Replicate Food Study

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

Healthy

United States
National Taiwan University Hospital

Unknown

Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation

Hearing Loss

Taiwan
National Institute of Allergy and Infectious Diseases...
AstraZeneca

Active, not recruiting

Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome (HESIL5R)

Hematologic Diseases | Leukocyte Disorders | Hypereosinophilia | Respiratory System Agents | Anti-Asthmatic Agents

United States
Takeda

Completed

Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis

Erosive Esophagitis

China, Taiwan, Korea, Republic of, Malaysia
Boehringer Ingelheim

Completed

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

Atrial Fibrillation

United States, Canada
Centre hospitalier de l'Université de Montréal...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Completed

Drug-drug Interaction Study in Healthy Male Volunteers Following the Administration of Pantoprazole and Rosuvastatin

Drug Interaction Potentiation

Canada
Jason Lang, M.D., M.P.H.
Nemours Children's Clinic; Thrasher Research Fund

Active, not recruiting

Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma (GenARA)

Asthma | Gastroesophageal Reflux

United States
HK inno.N Corporation

Completed

Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease

Erosive Reflux Disease

Korea, Republic of
Changhua Christian Hospital

Withdrawn

Oral vs Intravenous and Proton Pump Inhibitor (PPI）for Peptic Ulcer Bleeding (PUB)

Upper Gastrointestinal Bleeding
Washington University School of Medicine
TAP Pharmaceutical Products Inc.; Doris Duke Charitable Foundation

Completed

A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion

Otitis Media With Effusion

United States
Vanderbilt University Medical Center

Completed

Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?

Gastroesophageal Reflux | Larynx Disease

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Fasting Study

Healthy

United States
McGill University Health Centre/Research Institute...

Unknown

The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate (Pale Turbinate)

Rhinitis | GERD | Nasal Obstruction
Nycomed

Completed

Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD) (PANTHER)

Gastroesophageal Reflux Disease

Germany
Nycomed

Completed

Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders (PANDA)

Gastroesophageal Reflux Disease | Sleep Disorders | Non-Erosive Reflux Disease

Germany
Nycomed

Completed

Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease (PARADE)

Gastroesophageal Reflux Disease

Germany
Takeda

Completed

Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)

Gastroesophageal Reflux

United States
Takeda

Completed

Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)

Gastroesophageal Reflux Disease

Germany, Poland, Brazil, South Africa
Mohamed Saad
Abbott Nutrition; University of Louisville

Completed

Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.

Clostridium Difficile Colitis | Gastrointestinal Hemorrhage

United States
Takeda

Completed

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis

Erosive Esophagitis

China, Taiwan, Korea, Republic of, Malaysia
Southwest Oncology Group
Bill and Melinda Gates Foundation

Completed

S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)

Helicobacter Pylori Infection

Chile, Colombia, Costa Rica, Honduras, Mexico, Nicaragua
Kaohsiung Veterans General Hospital.

Completed

Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection

Helicobacter Pylori Infection

Taiwan
Addpharma Inc.

Recruiting

A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121

Gastro Esophageal Reflux

Korea, Republic of
Washington University School of Medicine

Active, not recruiting

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Pancreatic Cancer | Pancreatitis | Pancreas Cancer | Duodenal Cancer | Ampullary Cancer | Pancreas Neuroendocrine Tumor | Distal Extrahepatic Cholangiocarcinoma

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage

Peptic Ulcer Hemorrhage

United States
University of Medicine and Dentistry of New Jersey
National Institutes of Health (NIH)

Terminated

Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor

Esophageal Metaplasia

United States
University of Roma La Sapienza

Unknown

PPI Therapy Impact on GERD After Sleeve Gastrectomy

Gastro Esophageal Reflux | Bariatric Surgery Candidate | Barrett Esophagus

Italy
Far Eastern Memorial Hospital

Completed

Comparison of the Efficacy for Stress Ulcer Prophylaxis Between the Patients Received Lansoprazole OD and Control Group Weaning From Mechanical Ventilator in Respiratory Care Center: a Randomized Control Trial

Respiratory Failure

Taiwan
Dr. Waheed Rehman

Unknown

Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes

Diabetes Mellitus
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

Healthy

India
Takeda

Completed

Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)

Gastroesophageal Reflux | GERD | GORD

United Kingdom
Takeda

Completed

Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)

GERD

Hungary, Austria, Germany, Australia
Takeda

Terminated

The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)

Gastroesophageal Reflux Disease | Non-erosive Reflux Disease

Switzerland, Netherlands
National Taiwan University Hospital

Unknown

Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy (THC)

Eradication Rates of the Two Regimens

Taiwan
Ruttonjee Hospital

Completed

Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion

Peptic Ulcer/Erosions

China
Head and Neck Surgery Associates

Completed

Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease

Gastroesophageal Reflux | Nasal Polyps

United States
Northern Orthopaedic Division, Denmark
Aalborg University; Association of Danish Physiotherapists; The Danish Rheumatism... and other collaborators

Completed

Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement (MEDIC)

Osteoarthritis of the Knee

Denmark
National Institute of Diabetes and Digestive and...

Completed

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

Gastrinoma | Zollinger Ellison Syndrome

United States
Samsung Medical Center

Unknown

Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease

Laryngopharyngeal Reflux Disease

Korea, Republic of
McMaster University
The Physicians' Services Incorporated Foundation

Completed

Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICU (REVISE)

Stress Ulcer Prophylaxis

Canada, Australia, Saudi Arabia
Asan Medical Center
Inje University; Pacific Pharmaceuticals

Completed

Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication

Helicobacter Infection

Korea, Republic of
Far Eastern Memorial Hospital

Terminated

Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis

Stomach Ulcer

Taiwan
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours

Advanced Solid Tumours

Canada
Effexus Pharmaceutical
Southern Arizona VA Health Care System

Unknown

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

Heartburn | Gastroesophageal Reflux Disease (GERD) | Indigestion

United States
Takeda

Completed

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)

Gastroesophageal Reflux

Hungary, Austria, Germany, Poland
Takeda

Completed

Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)

Gastroesophageal Reflux Disease (GERD)

United Kingdom, Australia, Belgium, Spain, Austria, Germany, Argentina, Brazil, Canada, France, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Mexico, Poland, Portugal, Singapore, South Africa, Switzerland, Taiwan
Takeda

Completed

Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)

Gastroesophageal Reflux Disease (GERD) | Peptic Ulcers

Germany

3

Subscribe